Fuyuki Inagaki

National Center for Global Health and Medicine

EngineeringMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green”.

Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green

Cancer Science(2021)10.1111/cas.14809

N/A

0.464DataRank · unranked

21 citations

Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato +3 more

Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab–IR700 for Near-Infrared Photoimmunotherapy

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00262

N/A

0DataRank · unranked

20 citations

Fuyuki Inagaki, Ryuhei Okada, Adrian Rosenberg, Aki Furusawa, Peter L. Choyke +2 more

Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy

Cancers(2020)10.3390/cancers12123747

N/A

0DataRank · unranked

39 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Yasuhiro Maruoka +3 more

Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors

Cancers(2020)10.3390/cancers12092575

N/A

0DataRank · unranked

36 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato +4 more

Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice

Molecular Imaging(2020)10.1177/1536012120934965

N/A

0DataRank · unranked

6 citations

Daiki Fujimura, Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama +4 more

Wound healing after excision of subcutaneous tumors treated with near‐infrared photoimmunotherapy

Cancer Medicine(2020)10.1002/cam4.3247

N/A

0DataRank · unranked

5 citations

Fuyuki Inagaki, Takuya Kato, Ryuhei Okada, Hiroaki Wakiyama, Aki Furusawa +3 more

Norcyanine-Carbamates Are Versatile Near-Infrared Fluorogenic Probes

Journal of the American Chemical Society(2021)10.1021/jacs.1c02112

N/A

0DataRank · unranked

102 citations

Fuyuki Inagaki, Hisataka Kobayashi, Martin J. Schnermann, Syed Muhammad Usama

Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity

Advanced Therapeutics(2021)10.1002/adtp.202000269

N/A

0DataRank · unranked

46 citations

Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Peter L. Choyke +2 more

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

EBioMedicine(2021)10.1016/j.ebiom.2021.103345

N/A

0DataRank · unranked

45 citations

Aki Furusawa, Daniel W. Vermeer, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato +6 more

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0470

N/A

0DataRank · unranked

34 citations

Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.1c00184

N/A

0DataRank · unranked

31 citations

Ryuhei Okada, Yuto Goto, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama +9 more

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model

Cancer Science(2021)10.1111/cas.15013

N/A

0DataRank · unranked

25 citations

Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama +5 more

Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green

Molecular Pharmaceutics(2021)10.1021/acs.molpharmaceut.0c01107

N/A

0DataRank · unranked

24 citations

Daiki Fujimura, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Takuya Kato +3 more

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0041

N/A

0DataRank · unranked

53 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0313

N/A

0DataRank · unranked

31 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model

OncoImmunology(2022)10.1080/2162402x.2021.2019922

N/A

0DataRank · unranked

30 citations

Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto +5 more

Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy

Cancer Immunology Immunotherapy(2022)10.1007/s00262-021-03124-x

N/A

0DataRank · unranked

22 citations

Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Daiki Fujimura +6 more

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03205-5

N/A

0DataRank · unranked

14 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Hideyuki Furumoto +5 more

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

Pharmaceutics(2022)10.3390/pharmaceutics14102037

N/A

0DataRank · unranked

11 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +4 more

Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114390

N/A

0DataRank · unranked

14 citations

Hiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, Takuya Kato, Daiki Fujimura +6 more

Data from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

(2023)10.1158/2326-6066.c.6551037

N/A

0DataRank · unranked

0 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0517

N/A

0DataRank · unranked

81 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Daiki Fujimura, Hiroaki Wakiyama +5 more

Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment

Cancer Science(2024)10.1111/cas.16195

N/A

0DataRank · unranked

12 citations

Makoto Kano, Aki Furusawa, Takuya Kato, Ryuhei Okada, Hiroshi Fukushima +5 more